Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy

Am J Med Genet A. 2009 Feb;149A(2):286-9. doi: 10.1002/ajmg.a.32621.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cardiomyopathy, Hypertrophic / genetics*
  • DNA Mutational Analysis
  • Female
  • Heart Ventricles / pathology
  • Humans
  • Hypertrophy, Left Ventricular / genetics*
  • MEF2 Transcription Factors
  • Male
  • Middle Aged
  • Mutation*
  • Myogenic Regulatory Factors / genetics*

Substances

  • MEF2 Transcription Factors
  • Myogenic Regulatory Factors